𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinicopathological and molecular analysis of endometrial carcinoma associated with tamoxifen

✍ Scribed by Turbiner, Julia; Moreno-Bueno, Gema; Dahiya, Sonika; Sánchez-Estevez, Carolina; Hardisson, David; Prat, Jaime; Oliva, Esther; Palacios, José


Book ID
109887670
Publisher
Nature Publishing Group
Year
2008
Tongue
English
Weight
445 KB
Volume
21
Category
Article
ISSN
0893-3952

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Endometrial carcinoma associated with br
✍ Rosa E. Cuenca; Juan Giachino; Mark A. Arredondo; Ronald Hempling; Stephen B. Ed 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 524 KB

## BACKGROUND. Women treated with tamoxifen for breast cancer are at increased risk of endometrial cancer. This study examines the experience at Roswell Park Cancer Institute (RPCI) with women diagnosed with both endometrial carcinoma (EC) and breast carcinoma (BC) to determine the risk and stage

Esophageal carcinoma simultaneously asso
✍ Dr. Hoichi Kato; Yuji Tachimori; Hiroshi Watanabe; Shunji Mizobouchi; Hiroyasu I 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 559 KB

Among 1,420 patients with thoracic esophageal carcinoma, 85 (6.1 %) had synchronous gastric carcinoma. Seventy-two patients (84.7%) underwent esophagectomy . Their operative mortality and prognosis were similar to those without gastric carcinoma. Among them, 25 patients, of whom the majority had adv

Survival analysis of endometrial carcino
✍ Dominique E.S. Boks; Aliana P. Trujillo; Adri C. Voogd; Hans Morreau; Gemma G. K 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 71 KB 👁 1 views

## Abstract Endometrial carcinoma (EC) is the most common extracolonic tumor associated with hereditary nonpolyposis colorectal cancer (HNPCC). HNPCC increases the risk of EC compared to the general population. Patients with HNPCC have a better prognosis than patients with common sporadic colorecta

The incidence of subsequent endometrial
✍ Katsuyoshi Katase; Yuko Sugiyama; Katsuhiko Hasumi; Masataka Yoshimoto; Fujio Ka 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 2 views

## Background: Tamoxifen commonly is used as adjuvant therapy for all stages of breast carcinoma. however, several studies have suggested an association between the use of tamoxifen in breast carcinoma patients and the subsequent development of endometrial carcinoma. the objective of this study was